Tripharm SRL
The score of Tripharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +71 % Total assets +30 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Tripharm's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 19,829 € | ||||
| Equity | 221,293 € | ||||
| Cash | 202,250 € | ||||
| EBITDA | 53,116 € | ||||
| Total assets | 424,878 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Aug 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 31 Jul 2024
- Year ended 31 Dec 2022filed on 28 Jul 2023
- Year ended 31 Dec 2021filed on 29 Jul 2022
Tripharm's financial analysis
- Solvency52.1%sector median: 58.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Tripharm
Tripharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0860.240.342
- VAT number
- BE0860240342
- Peppol
- Registered · 0208:0860240342 · as of 04 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Aug 2003
- Registered office
- 3201 Aarschot
- Latest accounts
- 2025 · filed on 30 Aug 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Tripharm (SRL) has been based in Aarschot since 2003, active in: business and other management consultancy activities. For 2025, it reports a net profit of 19,829 € and equity of 221,293 €; its revenue is not published. Its solvency stands at 52.1%, below the median of its sector (58.4%).
Companies similar to Tripharm
Companies in the same business, of comparable size and area, outside its group.
- OLI4 Consulting & Recruitment Business and other management consultancy activities Genappe · balance sheet 424,897 €
- Atventures Business and other management consultancy activities Liège · balance sheet 424,940 €
- RuaNova Computer consultancy and computer facilities management activities Merchtem · balance sheet 424,987 €
- LUX Patrimony Business and other management consultancy activities Anderlecht · balance sheet 425,022 €
- Zymaco Business and other management consultancy activities Chaumont-Gistoux · balance sheet 424,712 €
- Huve Invest Business and other management consultancy activities Sprimont · balance sheet 425,085 €
- New Tech & Energy Consulting Business and other management consultancy activities Mol · balance sheet 424,649 €
- Palozo Business and other management consultancy activities Zandhoven · balance sheet 424,631 €
Frequently asked questions about Tripharm
What is the revenue of Tripharm?
Tripharm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Tripharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0860240342 for Tripharm, if the company is VAT-registered. Its company number (CBE) is 0860.240.342.
Where is the registered office of Tripharm?
According to the CBE register, the registered office of Tripharm is in 3201 Aarschot.
What is the equity of Tripharm?
At the close of the 2025 financial year, the equity of Tripharm amounts to 221,293 €, a solvency of 52.1% of total assets.
Who manages Tripharm?
The register lists 1 active mandates at Tripharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Tripharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →